Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 7, 2015, Pages

  Crowther, Caroline A ^a,b   Mckinlay, Christopher J D ^a   Middleton, Philippa ^b,c   Harding, Jane E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; BETAMETHASONE ACETATE PLUS BETAMETHASONE SODIUM PHOSPHATE; CORTICOSTEROID; INOTROPIC AGENT; NITRIC OXIDE; OXYGEN; PLACEBO; SURFACTANT;

ACADEMIC ACHIEVEMENT; ADRENAL INSUFFICIENCY; AIR LEAK SYNDROME; APGAR SCORE; ARTERIAL PRESSURE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BLINDNESS; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; BRAIN HEMORRHAGE; BREAST FEEDING; CEREBRAL PALSY; CHILD BEHAVIOR; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CORTICOSTEROID THERAPY; DEATH; DEVELOPMENTAL DELAY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; FEVER; GESTATIONAL AGE; GLUCOSE INTOLERANCE; HEAD CIRCUMFERENCE; HEALTH CARE COST; HEARING IMPAIRMENT; HEART VENTRICLE HYPERTROPHY; HEMATOMA; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INSOMNIA; INSULIN SENSITIVITY; INTELLECTUAL IMPAIRMENT; LABOR; LEARNING DISORDER; LENGTH OF STAY; LEUKOMALACIA; LUNG DISEASE; LUNG EDEMA; LUNG FUNCTION; MATERNAL CARE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; NAUSEA; NECROTIZING ENTEROCOLITIS; NEONATAL INTENSIVE CARE UNIT; NEWBORN CARE; NEWBORN INFECTION; OBSTETRIC DELIVERY; OSTEOPOROSIS; PARENTAL STRESS; PATENT DUCTUS ARTERIOSUS; PATIENT SATISFACTION; PERCEPTION DEAFNESS; PERIVENTRICULAR LEUKOMALACIA; PLACENTA WEIGHT; POSITIVE END EXPIRATORY PRESSURE; POSTNATAL DEPRESSION; POSTPARTUM HEMORRHAGE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL SEPSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT DISEASE; RETROLENTAL FIBROPLASIA; REVIEW; RISK REDUCTION; SEPSIS; SKINFOLD THICKNESS; SMALL FOR DATE INFANT; SUPPLEMENTATION; SURVIVAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TEMPERAMENT; TREATMENT DURATION; TREATMENT WITHDRAWAL; VOMITING; ADVERSE EFFECTS; DRUG EFFECTS; FEMALE; LUNG; META ANALYSIS; NEWBORN; PREGNANCY; PREMATURITY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETREATMENT;

ADRENAL CORTEX HORMONES; BETAMETHASONE; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETREATMENT;

EID: 85003056313     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003935.pub4     Document Type: Review

References (126)

1. Aghajafari F, Murphy K, Ohlsson A, Amankwah K, Matthews S, Hannah M. Multiple versus single courses of antenatal corticosteroids for preterm birth: a pilot study. Journal of Obstetrics and Gynaecology Canada: JOGC 2002;24(4):321-9.
2. Ashwood PJ, Crowther CA, Willson KJ, Haslam RR, Kennaway DK, Hiller JE, et al. Neonatal adrenal function after repeat dose prenatal corticosteroids: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2006;194:861-7.
3. Battin M, Bevan C, Harding J. Repeat doses of antenatal steroids and hypothalamic-pituitary-adrenal axis (HPA) function. American Journal of Obstetrics and Gynecology 2007;197:40.e1-40.e6.
4. Battin M, Bevan C, Harding J. Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomised trial. Archives of Disease in Childhood Fetal & Neonatal Edition 2012;97(2):F99-F105.
5. Battin MR, Bevan C, Morton SM, Harding JE. Repeat courses of antenatal corticosteroids do not alter hypothalamic-pituitary-adrenal axis function after birth; results of a randomised controlled trial. Pediatric Academic Societies Annual Meeting; 2004 May 1-4; San Francisco, USA. 2004.
6. Crosby DD, Ashwood PJ, Khong TY, Crowther CA. Effects of repeat dose prenatal corticosteroids on placental pathology: results from the ACTORDS trial. Journal of Paediatrics and Child Health 2011;47(Suppl 1):53.
7. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS, et al. Outcome at 2 years of age after repeat doses of antenatal corticosteroids. New England Journal of Medicine 2007;357:1179-89.
8. Crowther CA, Haslam RR, Doyle LW, Harding JE, Hiller JE, Robinson JS, for the ACTORDS Study Group. Repeat doses of prenatal corticosteroids for women at risk of preterm birth: follow-up of children at 2 years corrected age in the ACTORDS trial. Journal of Paediatrics and Child Health 2007;43(Suppl 1):A76.
9. Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS, for the Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 2006;367:1913-9.
10. Crowther CA, Hiller JE, Haslam RR, Doyle LW, Robinson JS. Repeat doses of prenatal corticosteroids for women at risk of preterm birth: the ACTORDS Trial 12 month follow up. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3-6; Perth, Australia. 2006:179.
11. Mildenhall L, Battin M, Bevan C, Kuschel C, Harding J. Repeat prenatal corticosteroid doses do not alter neonatal blood pressure or myocardial thickness: randomized, controlled trial. Pediatrics 2009;123(4):e646-e652.
12. Mildenhall L, Battin M, Morton S, Bevan C, Kuschel C, Harding J. Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth. Archives of Disease in Childhood. Fetal and Neonatal Edition 2006;91:F56-F60.
13. Mildenhall LFJ, Battin MR, Bevan C, Kuschel CA, Harding JE. Repeat doses of antenatal corticosteroids do not alter neonatal cardiovascular status after birth; a randomised controlled trial. Perinatal Society of Australia and New Zealand 10th Annual Congress; 2006 April 3-6; Perth, Australia. 2006:55.
14. Garite T, Kurtzman J, Maurel K, Clark R, for the Obstetrix Collaborative Research Network. Impact of a 'rescue course' of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. American Journal of Obstetrics and Gynecology 2009;200:248.e1-248.e9.
15. Kurtzman J, Garite T, Clark R, Maurel K, The Obstetrix Collaborative Research Network. Impact of a "rescue course" of antenatal corticosteroids (ACS): a multicenter randomized placebo controlled trial. American Journal of Obstetrics and Gynecology 2008;199(6 Suppl 1):S2.
16. Obstetrix Medical Group. A randomized trial comparing the impact of one versus two courses of ACS on neonatal outcome. ClinicalTrials.gov (www.clinicaltrials.gov) (accessed 20 February 2008).
17. Guinn D, Atkinson M, Sullivan L, Lee M, MacGregor S, Parilla B, et al. Single versus weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. Obstetrics & Gynecology 2003;101(1):195.
18. Guinn D, BMZ Study Group. Multicenter randomized trial of single versus weekly courses of antenatal corticosteroids (ACS). American Journal of Obstetrics and Gynecology 2001;184(1):S6.
19. Guinn DA, Atkinson MW, Sullivan L, Lee M, MacGregor S, Parilla B, et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery. JAMA 2001;286(13):1581-7.
20. Guinn DA, BMZ Study Group. Multicenter randomized trial of single versus weekly courses of antenatal corticosteroids (ACS): interim analysis. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S12.
21. Lee M, Davies J, Atkinson MW, Guinn D, BMZ Study Group. Efficacy of weekly courses of antenatal corticosteroids (ACS) in preterm premature rupture of the membranes. American Journal of Obstetrics and Gynecology 2001;184(1):S8.
22. Lee MJ, Davies J, Guinn D, Sullivan L, Atkinson MW, McGregor S, et al. Single versus weekly courses of antenatal corticosteroids in preterm premature rupture of membranes. Obstetrics & Gynecology 2004;103(2):274-81.
23. Mazumder P, Dutta S, Kaur J, Narang A. Single versus multiple courses of antenatal betamethasone and neonatal outcome: a randomized controlled trial. Indian Pediatrics 2008;45:650-2.
24. McEvoy C. Effects of single versus weekly courses of antenatal steroids (AS) on functional residual capacity in preterm infants: a randomized trial. Pediatric Research 2001;49(4):388A.
25. McEvoy C, Bowling S, Williamson K, Lozano D, Tolaymat L, Collins J, et al. Effects of single versus weekly courses of antenatal steroids (AS) on functional residual capacity in preterm infants: a randomized trial. Pediatric Academic Societies Annual Meeting; 2001 April 28-May 1; Baltimore Convention Centre, Baltimore, Maryland, USA. 2001:Abstract no: 2228.
26. McEvoy C, Bowling S, Williamson R, Lozano D, Tolaymat L, Izquierdo L, et al. The effect of a single remote course versus weekly courses of antenatal corticosteroids on functional residual capacity in preterm infants: a randomized trial. Pediatrics 2002;110:280-4.
27. McEvoy C, Schilling D, Clay N, Spitale P, Durand M. Neurodevelopmental outcome and growth in infants randomized to a single rescue course of antenatal steroids. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011:3829.270.
28. McEvoy C, Schilling D, Peters D, Tillotson C, Spitale P, Wallen L, et al. Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2010;202:544.e1-544.e9.
29. McEvoy C, Schilling D, Segel S, Spitale P, Wallen L, Bowling S, et al. Improved respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized trial. American Journal of Obstetrics and Gynecology 2008;199(Suppl 1):S228.
30. McEvoy C, Schilling D, Spitale P, Gravett M, Durand M. Pulmonary function and respiratory outcomes at 12-24 months in preterm infants randomized to a single rescue course of antenatal steroids. Pediatric Academic Societies' 2010 Annual Meeting; 2010 May 1-4; Vancouver, Canada. 2010.
31. McEvoy C, Schilling D, Spitale P, Wallen L, Segel S, Bowling S, et al. Improved respiratory compliance after a single rescue course of antenatal steroids: a randomized controlled trial. Pediatric Academic Societies Annual Meeting; 2007 May 5-8; Toronto, Canada. 2007.
32. McEvoy C, Schilling D, Spitale P, Wallen L, Segel S, Bowling S, et al. Improved respiratory compliance after a single rescue course of antenatal steroids: a randomized controlled trial. Pediatric Academic Societies Annual Meeting; 2008 May 2-6; Honolulu, Hawaii. 2008.
33. McEvoy C, Schilling D, Spitale P, Wallen P, Segel S, Bowling S, et al. Growth and respiratory outcomes after a single rescue course of antenatal steroids: a randomized trial. Pediatric Academic Societies Annual Meeting; 2009 May 2-5; Baltimore, USA. 2009.
34. McEvoy CT, Schilling D, Segal S, Spitale P, Wallen L, Bowling S, et al. Improved respiratory compliance in preterm infants < 34 weeks after a single rescue course of antenatal steroids. American Journal of Respiratory and Critical Care Medicine 2009;179:A4127.
35. Asztalos E, Murphy K, Hannah M, Willan A, MACS Collaborative Group. Outcomes of children at two years after multiple courses of antenatal corticosteroids for threatened preterm birth: the multiple antenatal corticosteroids study (MACS). Pediatric Academic Societies' 2010 Annual Meeting; 2010 May 1-4; Vancouver, Canada. 2010.
36. Asztalos EV, Murphy KE, Hannah ME, Willan AR, Matthews SG, Ohlsson A, et al. Multiple courses of antenatal corticosteroids for preterm birth study: 2-year outcomes. Pediatrics 2010;126:e1045-e1055.
37. Maternal Infant and Reproductive Health Research Unit. Multiple courses of antenatal steroids for preterm birth (MACS). Center for Mother, Infant, and Child Research (www.utoronto.ca/miru/macs/protocol02.htm) 2002.
38. Murphy K, Asztalos E, Hannah M, Willan A, Hewson S, Ohlsson A, et al. Multiple courses of antenatal corticosteroids for preterm birth study (MACS): results of the three month maternal post partum questionnaire. American Journal of Obstetrics and Gynecology 2009;201(6 Suppl 1):S173.
39. Murphy K, Hannah M, Willan A, Hewson S, Ohlsson A, Kelly E, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008;372:2143-51.
40. Murphy K, Willan A, Hannah M, Ohlsson A, Kelly E, Matthews S, et al. Do antenatal corticosteroids reduce fetal growth or gestational age at birth? A secondary analysis from the multiple courses of antenatal corticosteroids for preterm birth study (MACS). American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S226.
41. Murphy K, for the MACS Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth study. American Journal of Obstetrics and Gynecology 2007;197(6 Suppl 1):S2, Abstract no: 2.
42. Murphy KE, Hannah ME, Willan AR, Ohlsson A, Kelly EN, Matthews SG, et al. Maternal side-effects after multiple courses of antenatal corticosteroids (MACS): the three-month follow-up of women in the randomized controlled trial of MACS for preterm birth study. Journal of Obstetrics and Gynaecology Canada: JOGC 2011;33(9):909-21.
43. Janer C, Helve O, Pitkänen OM, Kari MA, Peltoniemi OM, Hallman M, et al. Expression of airway epithelial sodium channel in the preterm infant is related to respiratory distress syndrome but unaffected by repeat antenatal beta-methasone. Neonatology 2010;97(2):132-8.
44. Koivisto M, Peltoniemi OM, Saarela T, Tammela O, Jouppila P, Hallman M. Blood glucose level in preterm infants after antenatal exposure to glucocorticoid. Acta Paediatrica 2007;96(5):664-8.
45. Peltoniemi O, Kari, M, Lano A, Yliherva A, Puosi R, Lehtonen L, et al. Two-year follow-up of a randomized trial with repeated antenatal betamethasone. Archives of Disease in Childhood. Fetal and Neonatal Edition 2009;94(6):F402-F406.
46. Peltoniemi OM. 2-year follow-up of randomized trial on a single repeat dose of antenatal betamethasone in imminent preterm birth. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2008 May 2-6; Honolulu, Hawaii. 2008.
47. Peltoniemi OM, Kari MA, Halmesmaki E, Raudaskoski T, Tammela O, Uotila J, et al. The effect of second course of antenatal betamethasone (BM) on neonatal morbidity in preterm infants: a randomised trial. Pediatric Research 2005;58(2):404.
48. Peltoniemi OM, Kari MA, Jouppila P, Hallman M. The second rescue dose of antenatal betamethasone (BM) shortly before birth may increase respiratory morbidity in high risk preterm infants. Pediatric Academic Societies Annual Meeting; 2006 April 29-May 2; San Francisco, CA, USA. 2006.
49. Peltoniemi OM, Kari MA, Tammela O, Lehtonen L, Marttila R, Halmesmaki E, et al. Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth. Pediatrics 2007;119(2):290-8.
50. Pesonen A, Raiikonen K, Lano A, Peltoniemi O, Hallman M, Kari MA. Antenatal betamethasone and fetal growth in prematurely born children: Implications for temperament traits at the age of 2 years. Pediatrics 2009;123:e31-e37.
51. Carroll MA, VidaeffAC, Mele L, Wapner RJ, Mercer B, Peaceman AM, et al. Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroids. Obstetrics & Gynecology 2008;111(6):1352-8.
52. Church M. Auditory brainstem responses (ABRs) in neonates exposed to repeated courses of antenatal corticosteroids. Program of the Twenty Eighth Annual Midwinter Research Meeting of the Association for Research in Otolaryngology; 2005 Feb 19-24; New Orleans, Louisiana. 2005:Abstract no: 669.
53. Church MW, Wapner RJ, Mele LM, Johnson F, Dudley DJ, Spong CY, et al. Repeated courses of antenatal corticosteroids: Are there effects on the infant's auditory brainstem responses?. Neurotoxicology and Teratology 2010;32(6):605-10.
54. Fonseca L, Ramin SM, Mele L, Wapner RJ, Johnson F, Peaceman AM, et al. Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroids. Obstetrics & Gynecology 2009;114(1):38-44.
55. Hashima JN, Lai Y, Wapner RJ, Sorokin Y, Dudley DJ, Peaceman A, et al. The effect of maternal body mass index on neonatal outcome in women receiving a single course of antenatal corticosteroids. American Journal of Obstetrics and Gynecology 2010;202(3):263.e1-263.e5.
56. Sawady J, Mercer B, Wapner R, Zhao, Y, Sorokin Y, Johnson F, et al. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network beneficial effects of antenatal repeated steroids study: impact of repeated doses of antenatal corticosteroids on placental growth and histologic findings. American Journal of Obstetrics and Gynecology 2007;281:e1-e8.
57. Sorokin Y for the NICHD MFMU Network. Effect of maternal BMI, number of courses and timing of antenatal corticosteroids: association with neonatal anthropometric measurements. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S106.
58. Sorokin Y, Romero R, Mele L, Wapner RJ, Iams JD, Dudley DJ, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. American Journal of Perinatology 2010;27(8):631-40.
59. Sorokin Y, Romero R, for the NICHD MFMU Network. Elevated maternal serum IL-6 and CRP are associated with preterm delivery < 32 weeks and subsequent neonatal intraventricular hemorrhage. American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S62.
60. Wapner R. Long term follow-up of infants receiving single vs repeat courses of antenatal corticosteroids. American Journal of Obstetrics and Gynecology 2006;195(6 Suppl 1):S2.
61. Wapner R, Sorokin Y, Mele L, Johnson F, Dudley D, Spong CY, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. New England Journal of Medicine 2007;357:1190-8.
62. Wapner RJ, Sorokin Y, Thom EA, Johnson F, Dudley DJ, Spong CY, et al. Single versus weekly courses of antenatal corticosteroids: evaluation of safety and efficacy. American Journal of Obstetrics and Gynecology 2006;195(3):633-42.
63. Wapner RJ, for the NICHD MFMU Network. A randomized trial of single versus weekly courses of corticosteroids. American Journal of Obstetrics and Gynecology 2003;189(6 Suppl 1):S56.
64. Wapner RJ, for the NICHD MFMU Network. Maternal and fetal adrenal function following single and repeat courses of antenatal corticosteroids (ACS). American Journal of Obstetrics and Gynecology 2005;193(6 Suppl):S5.
65. Bontis N, Vavilis D, Tsolakidis D, Goulis DG, Tzevelekis P, Kellartzis D, et al. Comparison of single versus multiple courses of antenatal betamethasone in patients with threatened preterm labor. Clinical and Experimental Obstetrics and Gynecology 2011;38(2):165-7.
66. Mercer B, Egerman R, Beazley D, Sibai B, Carr T, Sepesi J. Steroids reduce fetal growth: analysis of a prospective trial. American Journal of Obstetrics and Gynecology 2001;184(1):S7.
67. Mercer B, Egerman R, Beazley D, Sibai B, Carr T, Sepesi J. Weekly antenatal steroids trial in women at risk of preterm birth: a randomized trial. American Journal of Obstetrics and Gynecology 2001;184(1):S6.
68. Sawady J, Mercer B. Impact of repeated doses of antenatal corticosteroids on placental growth and histology. American Journal of Obstetrics and Gynecology 2006;195(6 Suppl 1):S73.
69. Romejko-Wolniewicz E, Oleszczuk L, Zareba-Szczudlik J, Czajkowski K. Dosage regimen of antenatal steroids prior to preterm delivery and effects on maternal and neonatal outcomes. Journal of Maternal-Fetal and Neonatal Medicine 2013;26(3):237-41.
70. Thorp JA, Yeast JD, Cohen GR, Wickstrom EA, D' Angelo LJ. Repeated antenatal betamethasone and perinatal outcome. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S21.
71. Atarod Z, Taghipour M, Roohanizadeh H, Fadavi S, Taghavipour M. Effects of single course and multicourse betamethasone prior to birth in the prognosis of the preterm neonates: a randomized, double-blind placebo-control clinical trial study. Journal of Research in Medical Sciences 2014;19(8):715-9.
72. Ataroud Z. Single versus multiple courses of antenatal betamethasone: evaluation of preterm infant's outcome. IRCT Iranian Registry of Clinical Trials (www.irct.ir) (accessed 6 December 2010). IRCT138711261689N1 2010.
73. Crowther C, Doyle LW, Anderson P, Harding JE, Haslam RR, Hiller JE. Repeat dose(s) of prenatal corticosteroids for women at risk of preterm birth: early school-age outcomes (6 to 8 years) for the ACTORDS trial. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011:3123.6.
74. Crowther CA, Doyle LW, Anderson P, Harding JE, Haslam RR, Hiller JE, et al. Repeat dose(s) of prenatal corticosteroids for women at risk of preterm birth: Early school-age outcomes (6 to 8 years) for children in the ACTORDS trial. Journal of Paediatrics and Child Health 2011;47(Suppl 1):52-3.
75. McKinlay CJ, Cutfield WS, Battin MR, Dalziel SR, Crowther CA, Harding JE. Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: an RCT. Pediatrics 2015;135(2):e405-e415.
76. McKinlay CJD, Cutfield WS, Battin MR, Dalziel SR, Crowther CA. Cardiovascular risk factors after exposure to repeat antenatal betamethasone: early school-age follow-up of a randomised trial (ACTORDS). Journal of Paediatrics and Child Health 2011;47(Suppl 1):20.
77. McKinlay CJD, Cutfield WS, Battin MR, Dalziel SR, Crowther CA. Repeat antenatal betamethasone does not affect basal salivary cortisol at early school-age: a randomised controlled trial (ACTORDS). Journal of Paediatrics and Child Health 2011;47(Suppl 1):19.
78. McKinlay CJD, Cutfield WS, Battin MR, Dalziel SR, Crowther CA, Harding JE. Cardiovascular risk factors after exposure to repeat antenatal betamethasone: early school-age follow-up of a randomised trial (ACTORDS). Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011:1660.5.
79. McKinlay CJD, Cutfield WS, Battin MR, Dalziel SR, Crowther CA, Harding JE. Repeat antenatal betamethasone does not affect basal salivary cortisol at early school-age: a randomised controlled trial (ACTORDS). Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; 2011 April 30-May 3; Denver, Colorado, USA. 2011:2919.266.
80. McKinlay CJD, Cutfield WS, Battin MR, Dalziel SR, Crowther CA, Harding JE. Repeat antenatal betamethasone does not affect bone mass at early school-age: A randomised controlled trial (ACTORDS). Journal of Paediatrics and Child Health 2013;49(Suppl 2):49.
81. McKinlay CJD, Harding JE, Ashwood PJ, Dalziel SR, Doyle LW, Haslam RR, et al. Effect of repeat antenatal betamethasone on childhood lung function: A randomised controlled trial (ACTORDS). Journal of Paediatrics and Child Health 2013;49(Suppl 2):92-3.
82. Asztalos E, Willan A, Murphy K, Matthews S, Ohlsson A, Saigal S, et al. Association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years: multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5). BMC Pregnancy and Childbirth 2014;14(1):272.
83. Asztalos E, Willan A, Murphy K, Matthews S, Ohlsson A, Saigal S, et al. Multiple courses of antenatal corticosteroids for preterm birth study at 5 years of age (MACS-5): association between gestational age at birth, antenatal corticosteroids, and outcomes at 5 years of age (MACS-5). American Journal of Obstetrics and Gynecology 2014;210(1 Suppl):S321-S322.
84. Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S, et al. for the MACS-5 Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth study: Outcomes in children at 5 years of age (MACS-5). Journal of the American Medical Association Pediatrics 2013;167(12):1102-10.
85. Murphy KE, Willan AR, Hannah ME, Ohlsson A, Kelly EN, Matthews SG, et al. Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstetrics & Gynecology 2012;119(5):917-23.
86. Sohrabvand F, Behbahani B, Kazeminejad A. Effects of single versus multiple courses of corticosteroid therapy on pregnancy results in women with PPROM. Journal of Perinatal Medicine 2001;29 Suppl 1(Pt 2):528.
87. Adams H. Trial of the effects of antenatal multiple courses of steroids versus a single course (TEAMS): pilot study. Current Controlled Trials (http://www.controlled-trials.com) (accessed 4 November 2003) 2003.
88. Brocklehurst P, Gates S, Johnson A. Effects of multiple courses of antenatal steroids are uncertain [letter]. BMJ 2000;321:47.
89. Ashwood PJ, Crowther CA, Willson KJ, Haslam RR, Kennaway DJ, Hiller JE, et al. Neonatal adrenal function after repeat dose prenatal corticosteroids: a randomized controlled trial. American Journal of Obstetrics and Gynecology 2006;194:861-7.
90. Benediktsson R, Lindsay RS, Noble J, Secki JR, Edwards CRW. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993;341:339-41.
91. Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD006764.pub3]
92. Crowther C, Aghajafari F, Askie L, Asztalos E, Brocklehurse P, Bubner T, et al. Repeat prenatal corticosteroid prior to preterm birth: a systematic review and individual participant data meta-analysis for the PRECISE study group (prenatal repeat corticosteroid international IPD study group: assessing the effects using the best level of evidence) - study protocol. Systematic Reviews 2012;1(1):12.
93. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005;365(9474):1856-62.
94. Dalziel SR, Lim VK, Lambert A, McCarthy D, Parag V, Rodgers A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 2005;331(7518):665.
95. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, Newnham JP. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. Journal of Maternal-Fetal Medicine 1997;6:309-13.
96. Esplin M, Fausett M, Smith S, Oshiro B, Porter TF, Branch DW, et al. Multiple courses of antenatal steroids associated with a delay in long-term psychomotor development in children with birth weight < 1500 grams. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S24.
97. Fowden AL, Szemere J, Hughes RS, Forhead AJ. The effects of cortisol on the growth rate of the sheep fetus during late gestation. Journal of Endocrinology 1996;151:97-105.
98. French N, Hagan R, Evans S, Godfrey M, Newnham J. Repeated antenatal corticosteroids: behaviour outcomes in a regional population of very preterm infants. Pediatric Research 1998;43:214A.
99. French N, Hagan R, Evans S, Godfrey M, Newnham J. Repeated antenatal corticosteroids: size at birth and subsequent development. American Journal of Obstetrics and Gynecology 1999;180:114-21.
100. French N, Hagan R, Evans S, Mullan A, Newnham J. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behaviour. American Journal of Obstetrics and Gynecology 2004;190:588-95.
101. Hasbargen U, Reber D, Versmold H, Schulze A. Growth and development of children to 4 years of age after repeated antenatal steroid administration. European Journal of Pediatrics 2001;160:552-5.
102. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
103. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. American Journal of Respiratory and Critical Care Medicine 1997;156:178-84.
104. Jensen EC, Gallaher BW, Breier BH, Harding JE. The effect of a chronic maternal cortisol infusion on the late gestation fetal sheep. Journal of Endocrinology 2002;174:27-36.
105. Jobe AH. National Institutes of Health. Report of the Consensus Development Conference on the effect of corticosteroids for fetal lung maturation on perinatal outcomes. Bethesda, MD: US Department of Health and Human Services, Public Health Service, 1994:39-41.
106. Johnson A, Townshend P, Yudkin P, Bull D, Wilkinson AR. Functional abilities at age 4 years of children born before 29 weeks gestation. BMJ 1993;306:1715-8.
107. Laws PJ, Sullivan EA. Australia's mothers and babies 2003. Perinatal Statistics Series no. 16. Sydney: Australian Institute of Health and Welfare, National Perinatal Statistics Unit, 2005.
108. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
109. McKenna DS, Witter GM, Nagaraja HN, Samuels P. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function. American Journal of Obstetrics and Gynecology 2000;183:669-73.
110. McLaughlin KJ, Crowther CA, Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Australian and New Zealand Journal of Obstetrics and Gynaecology 2003;43:101-6.
111. Mildenhall LF, Battin MR, Morton SMB, Bevan C, Kuschel CA, Harding JE. Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth. Archives of Disease in Childhood Fetal and Neonatal Edition 2006;91:F56-F60.
112. Moise AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics 1995;95:845-50.
113. Newnham JP, Evans S, Godfrey M, Huang W, Ikegami M, Jobe A. Maternal, but not fetal, administration of corticosteroids restricts fetal growth. Journal of Maternal-Fetal Medicine 1999;8(3):81-7.
114. NIH Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8.
115. NIH Consensus Development Panel. Antenatal corticosteroids revisited: repeat courses. National Institutes of Health Consensus development conference statement. Obstetrics & Gynecology 2000;98:144-50.
116. Padbury JF, Ervin G, Polk D. Extrapulmonary effects of antenatally administered steroids. Journal of Pediatrics 1996;128:167-72.
117. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
118. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2]
119. Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD000510.pub2]
120. Seckl JR, Meaney MJ. Glucocorticoid programming. Annals of the New York Academy of Sciences 2004;1032:63-84.
121. Thorp JA, Etzenhouser J, O'Connor M, Jones A, Jones P, Belden B, et al. Effects of phenobarbital and multiple-dose antenatal/postnatal steroid on developmental outcome at age 7 years. American Journal of Obstetrics and Gynecology 2002;185(6):S87.
122. Tschanz SA, Danke BM, Burri PH. Influence of postnatally administered glucocorticoids on rat lung growth. Biology of the Neonate 1995;68:229-45.
123. Utama DP, Crowther CA. Transplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birth. Cochrane Database of Systematic Reviews 2011, Issue 9. [DOI: 10.1002/14651858.CD008981.pub2]
124. Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews 2000, Issue 2. [DOI: 10.1002/14651858.CD003935]
125. Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD003935.pub2]
126. Crowther CA, McKinlay CJD, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD003935.pub3]